Generic drugs firm to grow sideways

Shanghai Fosun Pharmaceutical, a unit of mainland conglomerate Fosun International, said it plans to grow horizontally through acquisitions of drug makers that offer synergies with its products.

"From an integration perspective, we are interested in buying scaleable drug manufacturing operations that could provide an imminent boost to our revenue, profitability, market share, as well as our brand awareness," Chen Qiyu, chairman and executive director of the firm, said yesterday.

via Business feed http://www.scmp.com/business/companies/article/1062695/generic-drugs-firm-grow-sideways